1.

Novel missense mutation in the caveolin-3 gene in a Belgian family with rippling muscle disease.

2.

Novel missense mutation in the caveolin-3 gene in a Belgian family with rippling muscle disease.

3.

Novel missense mutation in the caveolin-3 gene in a Belgian family with rippling muscle disease.

4.

Novel missense mutation in the caveolin-3 gene in a Belgian family with rippling muscle disease.

5.

Novel missense mutation in the caveolin-3 gene in a Belgian family with rippling muscle disease.

6.

Novel missense mutation in the caveolin-3 gene in a Belgian family with rippling muscle disease.

7.

Novel missense mutation in the caveolin-3 gene in a Belgian family with rippling muscle disease.

8.

Novel missense mutation in the caveolin-3 gene in a Belgian family with rippling muscle disease.

9.

Novel missense mutation in the caveolin-3 gene in a Belgian family with rippling muscle disease.

1.

Trends and predictors of transmitted drug resistance (TDR) and clusters with TDR in a local Belgian HIV-1 epidemic

2.

Trends and predictors of transmitted drug resistance (TDR) and clusters with TDR in a local Belgian HIV-1 epidemic

3.

Trends and predictors of transmitted drug resistance (TDR) and clusters with TDR in a local Belgian HIV-1 epidemic

4.

Trends and predictors of transmitted drug resistance (TDR) and clusters with TDR in a local Belgian HIV-1 epidemic

5.

Trends and predictors of transmitted drug resistance (TDR) and clusters with TDR in a local Belgian HIV-1 epidemic

6.

Trends and predictors of transmitted drug resistance (TDR) and clusters with TDR in a local Belgian HIV-1 epidemic

7.

Trends and predictors of transmitted drug resistance (TDR) and clusters with TDR in a local Belgian HIV-1 epidemic

1.

Instauration et optimisation d'une insulinothérapie en médecine générale : InsuStar, une étude observationnelle prospective belge dans le diabète de type 2 ; Initiating and intensi...

2.

Instauration et optimisation d'une insulinothérapie en médecine générale : InsuStar, une étude observationnelle prospective belge dans le diabète de type 2 ; Initiating and intensi...

3.

Instauration et optimisation d'une insulinothérapie en médecine générale : InsuStar, une étude observationnelle prospective belge dans le diabète de type 2 ; Initiating and intensi...

4.

Instauration et optimisation d'une insulinothérapie en médecine générale : InsuStar, une étude observationnelle prospective belge dans le diabète de type 2 ; Initiating and intensi...

5.

Instauration et optimisation d'une insulinothérapie en médecine générale : InsuStar, une étude observationnelle prospective belge dans le diabète de type 2 ; Initiating and intensi...

6.

Instauration et optimisation d'une insulinothérapie en médecine générale : InsuStar, une étude observationnelle prospective belge dans le diabète de type 2 ; Initiating and intensi...

7.

Instauration et optimisation d'une insulinothérapie en médecine générale : InsuStar, une étude observationnelle prospective belge dans le diabète de type 2 ; Initiating and intensi...

8.

Instauration et optimisation d'une insulinothérapie en médecine générale : InsuStar, une étude observationnelle prospective belge dans le diabète de type 2 ; Initiating and intensi...

9.

Instauration et optimisation d'une insulinothérapie en médecine générale : InsuStar, une étude observationnelle prospective belge dans le diabète de type 2 ; Initiating and intensi...

1.

Robot-Assisted Radical Hysterectomy in Cervical Carcinoma: The Belgian Experience.

2.

Robot-Assisted Radical Hysterectomy in Cervical Carcinoma: The Belgian Experience.

3.

Robot-Assisted Radical Hysterectomy in Cervical Carcinoma: The Belgian Experience.

4.

Robot-Assisted Radical Hysterectomy in Cervical Carcinoma: The Belgian Experience.

5.

Robot-Assisted Radical Hysterectomy in Cervical Carcinoma: The Belgian Experience.

6.

Robot-Assisted Radical Hysterectomy in Cervical Carcinoma: The Belgian Experience.

7.

Robot-Assisted Radical Hysterectomy in Cervical Carcinoma: The Belgian Experience.

8.

Robot-Assisted Radical Hysterectomy in Cervical Carcinoma: The Belgian Experience.

9.

Robot-Assisted Radical Hysterectomy in Cervical Carcinoma: The Belgian Experience.

1.

Health literacy among asthma patients and treatment expectations: results of a Belgian survey.

2.

Health literacy among asthma patients and treatment expectations: results of a Belgian survey.

3.

Health literacy among asthma patients and treatment expectations: results of a Belgian survey.

4.

Health literacy among asthma patients and treatment expectations: results of a Belgian survey.

5.

Health literacy among asthma patients and treatment expectations: results of a Belgian survey.

6.

Health literacy among asthma patients and treatment expectations: results of a Belgian survey.

7.

Health literacy among asthma patients and treatment expectations: results of a Belgian survey.

8.

Health literacy among asthma patients and treatment expectations: results of a Belgian survey.

9.

Health literacy among asthma patients and treatment expectations: results of a Belgian survey.

1.

Organization of a quality-assurance project in all Belgian multidisciplinary diabetes centres treating insulin-treated diabetes patients: 5 years' experience.

2.

Organization of a quality-assurance project in all Belgian multidisciplinary diabetes centres treating insulin-treated diabetes patients: 5 years' experience.

3.

Organization of a quality-assurance project in all Belgian multidisciplinary diabetes centres treating insulin-treated diabetes patients: 5 years' experience.

4.

Organization of a quality-assurance project in all Belgian multidisciplinary diabetes centres treating insulin-treated diabetes patients: 5 years' experience.

5.

Organization of a quality-assurance project in all Belgian multidisciplinary diabetes centres treating insulin-treated diabetes patients: 5 years' experience.

6.

Organization of a quality-assurance project in all Belgian multidisciplinary diabetes centres treating insulin-treated diabetes patients: 5 years' experience.

7.

Organization of a quality-assurance project in all Belgian multidisciplinary diabetes centres treating insulin-treated diabetes patients: 5 years' experience.

8.

Organization of a quality-assurance project in all Belgian multidisciplinary diabetes centres treating insulin-treated diabetes patients: 5 years' experience.

9.

Organization of a quality-assurance project in all Belgian multidisciplinary diabetes centres treating insulin-treated diabetes patients: 5 years' experience.

1.

Effets du glimepiride (Amarylle) chez le patient diabétique de type 2: Résultats de l'étude belge RECORD en médecine générale. ; Effects of glimepiride (Amarylle) in type 2 diabeti...

2.

Effets du glimepiride (Amarylle) chez le patient diabétique de type 2: Résultats de l'étude belge RECORD en médecine générale. ; Effects of glimepiride (Amarylle) in type 2 diabeti...

3.

Effets du glimepiride (Amarylle) chez le patient diabétique de type 2: Résultats de l'étude belge RECORD en médecine générale. ; Effects of glimepiride (Amarylle) in type 2 diabeti...

4.

Effets du glimepiride (Amarylle) chez le patient diabétique de type 2: Résultats de l'étude belge RECORD en médecine générale. ; Effects of glimepiride (Amarylle) in type 2 diabeti...

5.

Effets du glimepiride (Amarylle) chez le patient diabétique de type 2: Résultats de l'étude belge RECORD en médecine générale. ; Effects of glimepiride (Amarylle) in type 2 diabeti...

6.

Effets du glimepiride (Amarylle) chez le patient diabétique de type 2: Résultats de l'étude belge RECORD en médecine générale. ; Effects of glimepiride (Amarylle) in type 2 diabeti...

7.

Effets du glimepiride (Amarylle) chez le patient diabétique de type 2: Résultats de l'étude belge RECORD en médecine générale. ; Effects of glimepiride (Amarylle) in type 2 diabeti...

8.

Effets du glimepiride (Amarylle) chez le patient diabétique de type 2: Résultats de l'étude belge RECORD en médecine générale. ; Effects of glimepiride (Amarylle) in type 2 diabeti...

9.

Effets du glimepiride (Amarylle) chez le patient diabétique de type 2: Résultats de l'étude belge RECORD en médecine générale. ; Effects of glimepiride (Amarylle) in type 2 diabeti...

1.

The belgian experience in unrelated donor bone marrow transplantation: identification of center experience as an important prognostic factor.

2.

The belgian experience in unrelated donor bone marrow transplantation: identification of center experience as an important prognostic factor.

3.

The belgian experience in unrelated donor bone marrow transplantation: identification of center experience as an important prognostic factor.

4.

The belgian experience in unrelated donor bone marrow transplantation: identification of center experience as an important prognostic factor.

5.

The belgian experience in unrelated donor bone marrow transplantation: identification of center experience as an important prognostic factor.

6.

The belgian experience in unrelated donor bone marrow transplantation: identification of center experience as an important prognostic factor.

7.

The belgian experience in unrelated donor bone marrow transplantation: identification of center experience as an important prognostic factor.

8.

The belgian experience in unrelated donor bone marrow transplantation: identification of center experience as an important prognostic factor.

9.

The belgian experience in unrelated donor bone marrow transplantation: identification of center experience as an important prognostic factor.

1.

Risk adjusted benchmarking of abdominoperineal excision for rectal adenocarcinoma in the context of the Belgian PROCARE improvement project.

2.

Risk adjusted benchmarking of abdominoperineal excision for rectal adenocarcinoma in the context of the Belgian PROCARE improvement project.

3.

Risk adjusted benchmarking of abdominoperineal excision for rectal adenocarcinoma in the context of the Belgian PROCARE improvement project.

4.

Risk adjusted benchmarking of abdominoperineal excision for rectal adenocarcinoma in the context of the Belgian PROCARE improvement project.

5.

Risk adjusted benchmarking of abdominoperineal excision for rectal adenocarcinoma in the context of the Belgian PROCARE improvement project.

6.

Risk adjusted benchmarking of abdominoperineal excision for rectal adenocarcinoma in the context of the Belgian PROCARE improvement project.

7.

Risk adjusted benchmarking of abdominoperineal excision for rectal adenocarcinoma in the context of the Belgian PROCARE improvement project.

8.

Risk adjusted benchmarking of abdominoperineal excision for rectal adenocarcinoma in the context of the Belgian PROCARE improvement project.

9.

Risk adjusted benchmarking of abdominoperineal excision for rectal adenocarcinoma in the context of the Belgian PROCARE improvement project.

1.

Effectiveness of dolutegravir-based antiretroviral therapy in a real-world setting in a Belgian cohort of 4101 HIV patients.

2.

Effectiveness of dolutegravir-based antiretroviral therapy in a real-world setting in a Belgian cohort of 4101 HIV patients.

3.

Effectiveness of dolutegravir-based antiretroviral therapy in a real-world setting in a Belgian cohort of 4101 HIV patients.

4.

Effectiveness of dolutegravir-based antiretroviral therapy in a real-world setting in a Belgian cohort of 4101 HIV patients.

5.

Effectiveness of dolutegravir-based antiretroviral therapy in a real-world setting in a Belgian cohort of 4101 HIV patients.

6.

Effectiveness of dolutegravir-based antiretroviral therapy in a real-world setting in a Belgian cohort of 4101 HIV patients.

7.

Effectiveness of dolutegravir-based antiretroviral therapy in a real-world setting in a Belgian cohort of 4101 HIV patients.

8.

Effectiveness of dolutegravir-based antiretroviral therapy in a real-world setting in a Belgian cohort of 4101 HIV patients.

9.

Effectiveness of dolutegravir-based antiretroviral therapy in a real-world setting in a Belgian cohort of 4101 HIV patients.